Han Wen Chen
Direktor/Vorstandsmitglied bei SHENWAN HONGYUAN GROUP CO., LTD.
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Rong Yi Fang | M | 58 |
Xiamen University
| 11 Jahre |
Jie Qi | M | 58 | - | |
Zhao Bin He | M | 56 | 7 Jahre | |
Yong Qing Cheng | M | 62 |
Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China. | 32 Jahre |
De Qi Ren | M | 61 | 6 Jahre | |
Xu Han | M | 53 | - | |
Xiao Jian Wang | M | 51 |
Xiamen University
Xiamen International Bank Co., Ltd.
Xiamen International Bank Co., Ltd. Major BanksFinance Xiamen International Bank Co., Ltd. engages in the provision of commercial banking services. Its business scopes include personal and corporate deposits, loans, bonds, settlements, interbank borrowing, foreign exchanges, insurance, and credit services. The company was founded on August 31, 1985 and is headquartered in Shenzhen, China. | 11 Jahre |
Liang Xu | M | 49 | 9 Jahre | |
Qiang Wang | M | 52 | 4 Jahre | |
Wan Fu Zhou | M | 58 | 4 Jahre | |
Xing She Guan | M | 58 |
Xiamen University
| 8 Jahre |
Zheng Yu Yan | M | 63 |
Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China. | 25 Jahre |
Kwok Keung Yuen | M | 60 | 4 Jahre | |
Lei Zhao | M | 50 | 3 Jahre | |
Xiao Yu Zhang | M | 55 | 11 Jahre | |
Tin Chak Wong | M | 60 | 1 Jahre | |
Wei Li | M | 51 | 11 Jahre | |
Zhi Ren Lu | M | 60 | 3 Jahre | |
Ming Jun Xu | M | 61 | 6 Jahre | |
Ji Ye Mao | M | 61 | 2 Jahre | |
Bin Qian | M | 52 | 3 Jahre | |
Jiuyong Yin | M | 57 | 5 Jahre | |
Jin Yi Liu | M | 55 |
Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China. | 25 Jahre |
Siuman Yeung | F | 61 | 4 Jahre | |
Feng Zhang | M | 48 | 11 Jahre | |
Quan Sheng Ren | F | 56 | 4 Jahre | |
Xiao Lei Liu | M | 50 | 6 Jahre | |
Jing Gang Song | M | 50 | 2 Jahre | |
Jun Yang Yu | M | 49 |
Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China. | 24 Jahre |
Xiao Chun Liu | M | 65 | 4 Jahre | |
Bao Qun Fan | M | 52 |
Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China. | 3 Jahre |
Jia Cao | M | 40 |
Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China. | 10 Jahre |
Qi Lan | M | 68 | 4 Jahre | |
Jian Bin Wu | M | 61 | 7 Jahre | |
Fu Ning Hou | M | 60 | 8 Jahre | |
Jing Dong Liu | M | 56 | 7 Jahre | |
Xiang Dong Zhang | M | 67 | 4 Jahre | |
Hao Yi Cai | M | 70 | 6 Jahre | |
Jun Ma | M | 61 | 2 Jahre | |
Cong Lai Fan | M | 62 | 4 Jahre | |
Chang Qi Wu | M | 69 | 3 Jahre | |
Fu Rong Zhang | M | 71 |
Financial Accounting Society of China
| - |
Yi Yi Dai | M | 57 |
Xiamen University
School of Management Xiamen University
| 24 Jahre |
Chong En Bai | M | 61 | 4 Jahre | |
Lei Shi | M | 66 | 5 Jahre | |
Xiao Hui Li | M | 57 | 4 Jahre | |
Jiarong You | M | 70 |
China Audit Society
| - |
Lincoln Zhang | M | 52 | - | |
Hao Huang | M | 50 | 4 Jahre | |
De Ming Zhao | M | 58 |
Xiamen University
| 4 Jahre |
Chao Xiong Tang | M | 56 | 2 Jahre | |
Jian Fang Ye | M | 58 | 7 Jahre | |
Qing Hui Cai | M | 50 |
Xiamen University
| 19 Jahre |
Zhi Qing Li | M | 49 | 1 Jahre | |
Guo Hua Chi | M | 50 |
Xiamen University
Nanjing Audit University
| 11 Jahre |
Yan Meng | M | 69 |
Financial Accounting Society of China
China Audit Society
| - |
Hua Lin | M | - | 3 Jahre | |
Rong Xie | M | 71 |
China Audit Society
| - |
Guo Xin Mu | M | 57 | 2 Jahre | |
Xiaopeng Luo | M | 49 | 2 Jahre | |
Cheng Hao | M | - | 3 Jahre | |
Li Min Zhang | M | 69 |
China Audit Society
| - |
Lei Fu | M | 73 |
China Audit Society
| - |
Jian Xin Geng | M | 70 |
China Audit Society
| - |
Dong Lin Xia | M | 63 |
China Audit Society
| - |
Shuang Li | M | 80 |
China Audit Society
| - |
Ye Lin Li | M | 70 |
China Audit Society
| - |
Da Hai Xu | M | 62 |
Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China. | 25 Jahre |
Long Cheng Li | M | 59 | 4 Jahre | |
Pei Yong Gao | M | 65 |
China Audit Society
| - |
Feng Qin Zhang | F | 54 |
Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China. | 22 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Wei Dong Hou | M | 65 | 18 Jahre | |
Quanxun Zhang | M | 50 |
Xiamen University
| 15 Jahre |
Hu Cheng | M | 47 |
Xiamen University
| 11 Jahre |
Xiao Ming Chu | M | 62 | - | |
Ben Xi Ding | M | 69 | 11 Jahre | |
Wai Chu Tam | M | 78 | 3 Jahre | |
Chen Li Liu | M | 43 |
Xiamen University
| 7 Jahre |
Hong Xia Yang | F | 45 |
School of Management Xiamen University
| 6 Jahre |
Xing Zhong Wang | M | 56 | 3 Jahre | |
Ji Ping Yang | M | 53 | 2 Jahre | |
Xiangxi Wang | M | 61 | 3 Jahre | |
You Zhi Xiang | M | 60 |
Xiamen University
| 7 Jahre |
Ying Jie Zhong | F | 56 | 3 Jahre | |
Wei Wu | M | 54 | 6 Jahre | |
Shu Ye | M | 52 |
Xiamen University
| 6 Jahre |
Da Chen | M | 41 |
Xiamen University
| 8 Jahre |
Guang Huang | M | 61 |
Xiamen University
| 5 Jahre |
Bo Jiang | M | 69 | - | |
Jian Li | M | 71 | 6 Jahre | |
Jin Ping Shi | M | 45 |
Xiamen University
| 5 Jahre |
Jie Liu | M | 52 |
Xiamen University
| 5 Jahre |
Su Ping Peng | M | 65 | 2 Jahre | |
Xiang Hua You | M | 60 |
Xiamen University
| 5 Jahre |
Qing Huang | M | 59 | 19 Jahre | |
Ya Rong Du | M | 60 | 24 Jahre | |
Feng Chen | M | 52 |
Xiamen University
| 6 Jahre |
Yi Cheng Ji | M | 65 |
Xiamen University
| 7 Jahre |
Li Liu | M | 69 | 6 Jahre | |
Zhong Lin | M | 55 |
Xiamen University
| 6 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
China | 100 | 100,00% |
Vereinigte Staaten | 0 | -.--% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Han Wen Chen
- Persönliches Netzwerk